Browse > Article
http://dx.doi.org/10.15188/kjopp.2016.02.30.1.33

Inhibitory Effects of Extract of Rosae Rugosae Flos on the Acetylcholinesterase, β-secretase, and β-amyloid Aggregation  

Kim, Hyo Shin (College of Pharmacy, Woosuk University)
Kim, Ju Eun (College of Pharmacy, Woosuk University)
Leem, Jae-Yoon (College of Pharmacy, Woosuk University)
Publication Information
Journal of Physiology & Pathology in Korean Medicine / v.30, no.1, 2016 , pp. 33-39 More about this Journal
Abstract
Alzheimer's disease(AD), one of the most common forms of dementia, is characterized pathologically by the presence of intracellular neurofibrillary tangles and deposition of β-amyloid(Aβ) peptides of 40-42 residues. Aβ has been believed to be neurotoxic and now is also considered to have a role on the mechanism of memory dysfunction. Only a few acetylcholinesterase(AChE) inhibitors have been developed for treatment of AD, although the numbers of patients are rapidly increasing within aging society. Here, we show that ethanol extract of Rosae Rugosae Flos(RR) or its butanol fraction reduce the enzyme activity of AChE and BACE1(β-site APP cleaving enzyme 1). Furthermore, We found that RR inhibits Aβ aggregation and removes Aβ aggregates by Transmission electron microscopy(TEM). In addition, RR reduces the free radical of 2, 2-diphenyl-1-picrylhydrazyl(DPPH). We suggest that Rosae Rugosae Flos may be useful as a herbal medicine to treat AD.
Keywords
Alzheimer's disease; Rosae Rugosae Flos; Acetylcholinesterase; BACE; β-Amyloid aggregation; Antioxidant;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Koo, J.S., Seo, B.l., Park, J.H., Roh, S.S. Analysis of papers on Oriental herbal medicines(prescriptions and herbs) for dementia. Kor. J. Herbology. 25(3):131-137, 2010.
2 Kim, S.T., Kang, H.W., Han, P.L., Cho, H.K., Kim, T.H., Lyu, Y.S., Son, H.J. Effects of Antidementia on LMK02 in APP-transgenic Fly. J. of Oriental Neuropsychiatry. 19(2):151-163. 2008.
3 Kim, T.Y., Kim, C.J., Oh, J.W. The current status about Alzheimer’s dementia in the journal of oriental neuropsychiatry for evidence based medicine. J of Oriental neuropsychiatry. 25(3):287-296, 2014.   DOI
4 Perry, E.K., Peryy, P.H., Blessed, G., Tomlinson, B.E. Necropsy evidence of central cholinergic deficts in senile dementia. Lancet. 1: 8004-8189, 1997.
5 Browen, D.M., Benton, J.S., Spillane, J.A., Smith, C.C., Allen, S.J. Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients. J. Neurol. Sci. 57: 191-202, 1982.   DOI
6 Schroder, H., Giacobini, E., Struble, R.G., Luiten, P.G., Zilles, K., Strosberg, A.D. Muscarinic cholinoceptive neurons in the frontal cortex in Alzheimer’s disease. Brain Res. Bull. 27: 631-636, 1991.   DOI
7 Polinsky, R.J. Clinical pharmacology of rivastigmine: A new generation acetylcholinesterase inhibitor for the treatment of Alzheimer’s disease. Clin. Ther. 20: 634-647, 1998.   DOI
8 Kwak, J.H., Jeong, C.H., Kim, J.H., Choi, G.N., Shin, Y.H., Lee, S.C., Cho, S.H., Choi, S.G., Heo, H.J. Acetylcholinesterase inhibitory effect of green tea extracts according to storage condition. Korean J. Food Sci. Technol. 41(4):435-440, 2009.
9 Fu, H., Dou, J., Li, W., Cui, W., Mak, S., Hu, Q., Luo, J., Lam, C.S., Pang, Y., Youdim, M.B. and Han, Y. Promising multifunctional anti-Alzheimer's dimer bis(7)-Cognitin acting as an activator of protein kinase C regulates activities of alpha-secretase and BACE-1 concurrently. Eur. J. Pharmacol. 623(1-3):14-21, 2009.   DOI
10 Yu, G., Nishimura, M., Arawaka, S., Levitan, D., Zhang, L., Tandon, A., Song, Y.Q., Rogaeva, E., Chen, F., Kawarai, T., Supala, A., Levesque, L., Yu, H., Yang, D.S., Holmes, E., Milman, P., Liang, Y., Zhang, D.M., Xu, D.H., Sato, C., Rogaev, E., Smith, M., Janus, C., Zhang, Y., Aebersold, R.,Farrer, L.S., Sorbi, S., Bruni, A., Fraser, P., St. George-Hyslop, P. Nicastrin modulates presenilin-mediatednotch/glp-1 signal transduction and betaAPP processing. Nature 407: 48-54, 2000.   DOI
11 Lee, S.F., Shah, S., Li, H., Yu, C., Han, W., Yu, G Mammalian APH-1 interacts with presenilin and nicastrin and is required for intramembrane proteolysis of amyloid-beta precursor protein and Notch. J. Biol. Chem. 277: 45013-45019, 2002.   DOI
12 Steiner, H., Winkler, E., Edbauer, D., Prokop, S., Basset, G., Yamasaki, A., Kostka, M. and Haass, C. PEN-2 is an integral component of the γ-secretase complex required for coordinated expression of presenilin and nicastrin. J. Biol.Chem. 277: 39062-39061, 2002.   DOI
13 Robert, V., Brian, D. Bennett and Safura babu-Khan. β-secretase cleavage of Alzheimer's precursor protein by the transmembraneaspartic protease BACE. Science. 22: 735-741, 1999.
14 Yan, R., Vassar, R. Targeting the β secretase BACE1 for Alzheimer's disease therapy. Lancet Neurol. 13(3):319-329, 2014.   DOI
15 Lee, H.J., Lee, D.Y., Noh, Y.H., Yun, J.Y., Chung, Y.H., Kim, S.S., Lee, W.B. Protective Effect of Green Tea Extract on Neuronal Cell Death in Alzheimer Model using β-amyloid Peptide. The Korean J. Anat. 38(6):543-552, 2005.
16 Morris, J.C. Classification of dementia and Alzheimer's disease. Acta Neurol. Scand. 165: 41-50, 1996.   DOI
17 Zhao, L.N., Long, H., Mu, Y., Chew, L.Y. The toxicity of amyloid β oligomers. Int J Mol Sci. 13(6):7303-7327, 2012.   DOI
18 Yang, F., Lim, G.P., Begum, A.N., Ubeda, O.J., Simmons, M.R., Ambegaokar, S.S., Chen, P.P., Kayed, R., Glabe, C.G., Frautschy, S.A., Cole, G.M. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.J Biol Chem. Feb 18;280(7):5892-5901, 2005.   DOI
19 http://kosis.kr/statHtml/statHtml.do?orgId=101&tblId=DT_1B35001
20 Iqbal, K., Sisodia, S.S. and Winblad, B. Alzheimer's disease. Advances in etionlogy, pathogenesis and therapeutics. John Wiley & Sons, Ltd. 2001.
21 Selkoe, D.J. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8: 447-453, 1998.   DOI
22 Strittmatter, W.J., Weisgraber, K.H., Huang, D.Y., Dong, L.M., Salvesen, G.S., Pericak-Vance, M., Schmechel, D., Saunders, A.M., Goldgaber, D. and Roses, A.D. Binding of human apolipoprotein E to synthetic amyloid beta peptide isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. 90: 8098-8102, 1993.   DOI
23 Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L. and Pericak-Vance, M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923, 1993.   DOI
24 Selkoe, D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399: 23-31, 1999.   DOI
25 Jann, M.W. Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease. Pharmacotherapy. 20: 1-12, 2000.   DOI
26 Vassar, R., Bennett, B.D., Babu-Khan, S., Kahn, S., Mendiaz, E.A., Denis, P., Teplow, D.B., Ross, S., Amarante, P., Loeloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson, S., Lile, J., Jarosinski, M.A., Biere, A.L., Curran, E., Burgess, T., Louis, J.C., Collins, F., Treanor, J., Rogers, G. and Citron, M. β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286: 735-741, 1999.   DOI
27 Sugimoto, H. Donepezil hydrochloride. a treatment drug for Alzheimer's disease. Chem. Rec. 1: 63-73, 2001.   DOI
28 Zarotsky, V., Sramek, J.J. and Cutler, N.R. Galantamine hydrobromide. an agent for Alzheimer's disease. Am. J. Health Syst. Pharm. 60: 446-452, 2003.
29 Colin K., Combs, Derrick E. Johnson, J. Colleen Karlo, Steven B. Canndy and Gary E. Landreth. Inflammatory mechanisms in Alzheimer's Disease: Inhibition ofβ-Amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ Agonists. The journal of Neuroscience. 20(2):558-567, 2000.
30 Yan, Q., Zhang, J., Liu, H., Babu-Khan, S., Vassar, R., Biere, A.L., Citron, M., Landreth, G. Anti-inflammatory drug therapy alters β-amyloid processing and deposition in an animal model of Alzheimer's Disease. The journal of Neuroscience. 23(20):7504-7509, 2003.
31 Kim, E.J., Kim, G.Y. Hypoglycemic and Hypolipidemic Effect of Rosa rugosa Radix in Streptozotocine-induced Diabetic Rats. Korean Journal of Oriental Physiology and Pathology. 24(5):866-871, 2010.
32 Park, J.H. Medical Plants of Korea. Shinilbooks. 1: 668, 2012.